Literature DB >> 9930303

Successful use of a plant gene in the treatment of cancer in vivo.

M L Cortés1, P de Felipe, V Martín, M A Hughes, M Izquierdo.   

Abstract

A new strategy for cancer gene therapy has been developed using a plant gene which encodes the enzyme, linamarase, that hydrolyzes the cyanogenic glucoside substrate, linamarin, into glucose, acetone and cyanide. Retroviral vectors that carry linamarase as a potential killer-suicide gene cause a marked sensitization to the innocuous substrate, linamarin, followed by cell death. We show that the system can eradicate very large intracerebral gliomas in vivo helped by a cyanide bystander effect. Animals showing a total regression of the tumor by magnetic resonance imaging (MRI), do not show other appreciable toxic effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9930303     DOI: 10.1038/sj.gt.3300751

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  5 in total

1.  On the biomarkers and mechanisms of konzo, a distinct upper motor neuron disease associated with food (cassava) cyanogenic exposure.

Authors:  Roman M Kassa; Nyamabo L Kasensa; Victor H Monterroso; Robert J Kayton; John E Klimek; Larry L David; Kalala R Lunganza; Kazadi T Kayembe; Marina Bentivoglio; Sharon L Juliano; Desire D Tshala-Katumbay
Journal:  Food Chem Toxicol       Date:  2010-06-09       Impact factor: 6.023

2.  Identification of essential active-site residues in the cyanogenic beta-glucosidase (linamarase) from cassava (Manihot esculenta Crantz) by site-directed mutagenesis.

Authors:  Z Keresztessy; K Brown; M A Dunn; M A Hughes
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

3.  Therapeutic protein transduction of mammalian cells and mice by nucleic acid-free lentiviral nanoparticles.

Authors:  Nils Link; Corinne Aubel; Jens M Kelm; René R Marty; David Greber; Valentin Djonov; Jean Bourhis; Wilfried Weber; Martin Fussenegger
Journal:  Nucleic Acids Res       Date:  2006-01-30       Impact factor: 16.971

Review 4.  Gene therapy for carcinoma of the breast: Genetic toxins.

Authors:  G Vassaux; N R Lemoine
Journal:  Breast Cancer Res       Date:  1999-12-17       Impact factor: 6.466

Review 5.  Genetically Encoded Activators of Small Molecules for Imaging and Drug Delivery.

Authors:  Zacharias Thiel; Jade Nguyen; Pablo Rivera-Fuentes
Journal:  Angew Chem Int Ed Engl       Date:  2020-02-28       Impact factor: 15.336

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.